Search

Search Results
Results 1091 - 1100 of 1124 for Diabetes Type II
  • Phosphoproteomics in Research
    Life Sciences - 23 Aug 2018
    Phosphoproteomics is an important tool in the life sciences, allowing for the study of regulatory changes with variation in conditions and time.
  • Micardis
    Drug - 13 Oct 2025
    Consumer Medicine Information (CMI) about Micardis intended for persons living in Australia.
  • The role of transcription factors in next-gen drug discovery
    White Paper - 26 Aug 2025
    Discover how transcription factors are revolutionizing drug discovery.
  • Trikafta
    Drug - 11 Aug 2025
    Consumer Medicine Information (CMI) about Trikafta intended for persons living in Australia.
  • Voltaren Rapid
    Drug - 17 Jul 2025
    Consumer Medicine Information (CMI) about Voltaren Rapid intended for persons living in Australia.
  • The many applications of CD40-CD40L
    White Paper - 1 Jul 2025
    Discover the many uses of CD40-CD40L for autoimmune and neurological disease research.
  • Ataris
    Drug - 15 May 2025
    Consumer Medicine Information (CMI) about Ataris intended for persons living in Australia.
  • Contrave 8/90
    Drug - 28 Apr 2025
    Consumer Medicine Information (CMI) about Contrave 8/90 intended for persons living in Australia.
  • Enclomiphene in Clinical Practice: Mechanism, Efficacy, and Safety Consideration
    Life Sciences - 9 Apr 2025
    Enclomiphene citrate effectively treats male hypogonadism by boosting testosterone and preserving sperm production without the side effects of traditional TRT.
  • Abiraterone-Teva 250mg
    Drug - 10 Nov 2024
    Consumer Medicine Information (CMI) about Abiraterone-Teva 250mg intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback